C.Q. Pharmaceutical Holding Past Earnings Performance
Past criteria checks 2/6
C.Q. Pharmaceutical Holding has been growing earnings at an average annual rate of 1.7%, while the Healthcare industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 20.8% per year. C.Q. Pharmaceutical Holding's return on equity is 4.3%, and it has net margins of 0.7%.
Key information
1.7%
Earnings growth rate
1.7%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 20.8% |
| Return on equity | 4.3% |
| Net Margin | 0.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How C.Q. Pharmaceutical Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 80,123 | 592 | 3,770 | -1 |
| 31 Dec 23 | 80,119 | 655 | 3,700 | 0 |
| 30 Sep 23 | 75,682 | 690 | 4,150 | 6 |
| 30 Jun 23 | 75,869 | 1,065 | 3,720 | 4 |
| 31 Mar 23 | 71,571 | 1,006 | 3,533 | 5 |
| 31 Dec 22 | 67,829 | 952 | 3,410 | 3 |
| 30 Sep 22 | 66,833 | 1,104 | 3,242 | 7 |
| 30 Jun 22 | 65,084 | 969 | 3,529 | 7 |
| 31 Mar 22 | 63,938 | 1,038 | 3,476 | 7 |
| 31 Dec 21 | 62,521 | 1,005 | 3,360 | 10 |
| 30 Sep 21 | 61,022 | 954 | 3,149 | 5 |
| 30 Jun 21 | 58,266 | 1,022 | 2,921 | 5 |
| 31 Mar 21 | 52,016 | 880 | 2,621 | 6 |
| 31 Dec 20 | 45,220 | 884 | 2,319 | 3 |
| 30 Sep 20 | 39,096 | 755 | 2,042 | 4 |
| 30 Jun 20 | 34,703 | 624 | 1,875 | 3 |
| 31 Mar 20 | 33,599 | 726 | 1,751 | 3 |
| 31 Dec 19 | 33,844 | 788 | 1,690 | 3 |
| 30 Sep 19 | 32,536 | 888 | 1,707 | -1 |
| 30 Jun 19 | 29,897 | 844 | 1,483 | 0 |
| 31 Mar 19 | 27,641 | 700 | 1,512 | 0 |
| 31 Dec 18 | 25,803 | 691 | 1,387 | 0 |
| 30 Sep 18 | 22,021 | 123 | 1,233 | 1 |
| 30 Jun 18 | 21,501 | 715 | 1,302 | 1 |
| 31 Mar 18 | 21,385 | 613 | 1,301 | 1 |
| 31 Dec 17 | 21,190 | 590 | 1,313 | 0 |
| 30 Sep 17 | 19,170 | 1,723 | 1,352 | 0 |
| 31 Dec 16 | 20,487 | 956 | 1,194 | 0 |
| 31 Dec 15 | 19,419 | 394 | 1,268 | 0 |
Quality Earnings: 000950 has high quality earnings.
Growing Profit Margin: 000950's current net profit margins (0.7%) are lower than last year (1.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 000950's earnings have grown by 1.7% per year over the past 5 years.
Accelerating Growth: 000950's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 000950 had negative earnings growth (-41.2%) over the past year, making it difficult to compare to the Healthcare industry average (-1%).
Return on Equity
High ROE: 000950's Return on Equity (4.3%) is considered low.